Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$13.3B
sum of reported positions
Reported positions
626
Changes vs prior quarter
606
216 new · 51 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 329 measured positions in 8 quarters, the typical new or larger position finished −1.9 pts against the S&P 500 and 43% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 4.92M | $366M | 2.8% | |
VANGUARD TAX-MANAGED FDS | 4.84M | $345M | 2.6% |
| 16.8M | $322M | 2.4% | |
SPDR SERIES TRUST | 3.3M | $302M | 2.3% |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $13.7B | $13.3B |
| Positions | 461 | 626 |
| Biggest line | — | Williams Companies 3% |
| 7.7M |
| $246M |
| 1.9% |
| 5.92M | $218M | 1.6% |
| 886K | $212M | 1.6% |
| 3.33M | $181M | 1.4% |
INVESCO EXCHANGE TRADED FD T | 841K | $179M | 1.3% |
| 619K | $166M | 1.2% |
| 1.04M | $153M | 1.1% |
| 483K | $140M | 1.1% |
ONEOK INC NEW | 1.52M | $132M | 1.0% |
| 1.99M | $132M | 1.0% |
| 507K | $121M | 0.9% |
| 2.11M | $119M | 0.9% |
| 303K | $113M | 0.9% |
| 777K | $111M | 0.8% |
| 884K | $109M | 0.8% |
| 902K | $106M | 0.8% |
| 2.84M | $103M | 0.8% |
| 886K | $99.1M | 0.7% |
| 1.24M | $97.9M | 0.7% |
| 2.18M | $95.5M | 0.7% |
| 591K | $91.2M | 0.7% |
F5, Inc. (FFIV)
1,055 shares
American Express (AXP)
1,297 shares
Dollar Tree (DLTR)
3,622 shares
Western Alliance Bancorporation (WAL)
6,420 → 5,325 shares (−17%)
Arch Capital Group (ACGL)
4,504 shares
Cboe Global Markets (CBOE)
1,800 shares
Workday, Inc. (WDAY)
3,549 shares
Royalty Pharma (RPRX)
7,705 shares
D. R. Horton (DHI)
2,638 shares
Kinross Gold (KGC)
42K → 18K shares (−57%)
Citizens Financial Group (CFG)
6,096 shares
Incyte (INCY)
3,765 shares
U.S. Bancorp (USB)
7,040 shares
United Therapeutics (UTHR)
784 shares
Uranium Energy (UEC)
41K → 40K shares (−3%)
Astera Labs (ALAB)
872 shares
Exelon (EXC)
9,001 shares
PPL Corporation (PPL)
11K shares
Disney (DIS)
25K → 4,299 shares (−83%)
Ameren (AEE)
3,640 shares
J.B. Hunt (JBHT)
132K → 1,404 shares (−99%)
Credo Technology Group Holding (CRDO)
1,492 shares
Open Text (OTEX)
18K shares
Labcorp (LH)
1,443 shares
AutoZone (AZO)
126 shares